Dr. Julio Atencio, Oftalmólogo, Catarata & Refractiva Posts - TopicsExpress



          

Posts by Dr. Julio Atencio, Oftalmólogo, Catarata & Refractiva



MANF receives orphan drug designation for retinitis
MANF receives orphan drug designation for retinitis pigmentosa MANF, an investigational drug, has received orphan drug designation for the treatment ...
HARBOR study: visual, anatomic improvements maintained at 2
HARBOR study: visual, anatomic improvements maintained at 2 years Ophthalmology. 2014; doi:10.1016/j.ophtha.2014.05.009. Ranibizumab improved vision...
DNA test discerned bacteria responsible for Trachoma Dean D.
DNA test discerned bacteria responsible for Trachoma Dean D. Emerg Infect Dis. 2013;doi:10.3201/eid1912.130656. A commercial DNA microarray assay su...
PRK corrects myopia with high predictability up to 19 years
PRK corrects myopia with high predictability up to 19 years postoperatively J Refract Surg. 2013;29(5):312-319. Eyes with low myopia had better refr...
SD-OCT With a 3-Mirror Lens is Definitive in Differentiating
SD-OCT With a 3-Mirror Lens is Definitive in Differentiating Retinoschisis From Retinal Detachment Acta Ophthalmol 2013 Jun 15;[EPub Ahead of Print],...
The Efficacy of Optic Nerve Ultrasonography for Differentiating
The Efficacy of Optic Nerve Ultrasonography for Differentiating Papilloedema From Pseudopapilloedema in Eyes With Swollen Optic Discs Acta Ophthalmol...
Effectiveness of Nonpharmacologic Treatments for Acute Seasonal
Effectiveness of Nonpharmacologic Treatments for Acute Seasonal Allergic Conjunctivitis Ophthalmology 2013 Sep 23;[EPub Ahead of Print], PS Bilkhu, J...

Trending Topics




© 2015